These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24384000)

  • 1. Reduced bone mineral density in Japanese premenopausal women with systemic lupus erythematosus treated with glucocorticoids.
    Banno S; Matsumoto Y; Naniwa T; Hayami Y; Sugiura Y; Yoshinouchi T; Ueda R
    Mod Rheumatol; 2002 Dec; 12(4):323-8. PubMed ID: 24384000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women.
    Sinigaglia L; Varenna M; Binelli L; Zucchi F; Ghiringhella D; Gallazzi M; Limonta M; Zeni S; Fantini F
    J Rheumatol; 1999 Jun; 26(6):1280-4. PubMed ID: 10381043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
    Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
    Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage.
    Becker A; Fischer R; Scherbaum WA; Schneider M
    Lupus; 2001; 10(11):809-14. PubMed ID: 11789491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [BONE MINERAL DENSITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS--OUR RESULTS].
    Gracanin AG; Marković I; Loncarević J; Golob M; Morović-Vergles J
    Reumatizam; 2015; 62(2):16-21. PubMed ID: 26882799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids.
    Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah S; Chow SK; Goh EM
    Lupus; 2009 Feb; 18(2):178-81. PubMed ID: 19151123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four years follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus.
    Uaratanawong S; Deesomchok U; Hiransuttikul N; Uaratanawong S
    J Med Assoc Thai; 2004 Nov; 87(11):1374-9. PubMed ID: 15825716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only.
    Lai CC; Chen WS; Chang DM; Tsao YP; Wu TH; Chou CT; Tsai CY
    Osteoporos Int; 2015 Feb; 26(2):601-10. PubMed ID: 25270396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
    Iwamoto J; Takeda T; Sato Y; Uzawa M
    J Bone Miner Metab; 2005; 23(3):238-42. PubMed ID: 15838627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus.
    Mok CC; Wong SN; Ma KM
    Rheumatology (Oxford); 2012 Mar; 51(3):468-75. PubMed ID: 22096013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
    Lane NE; Sanchez S; Genant HK; Jenkins DK; Arnaud CD
    Osteoporos Int; 2000; 11(5):434-42. PubMed ID: 10912846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of alendronate on glucocorticoid-induced osteoporosis in Japanese women with systemic autoimmune diseases: versus alfacalcidol.
    Takeda S; Kaneoka H; Saito T
    Mod Rheumatol; 2008; 18(3):271-6. PubMed ID: 18427724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus.
    Cramarossa G; Urowitz MB; Su J; Gladman D; Touma Z
    Lupus; 2017 Apr; 26(4):365-372. PubMed ID: 27522094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of low bone mineral density in Brazilian patients with systemic lupus erythematosus and its relationship with the disease damage index and other associated factors.
    Souto MI; Coelho A; Guo C; Mendonça LM; Pinheiro MF; Papi JA; Farias ML
    J Clin Densitom; 2012; 15(3):320-7. PubMed ID: 22321657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and predictors of fragility fractures in systemic lupus erythematosus.
    Yee CS; Crabtree N; Skan J; Amft N; Bowman S; Situnayake D; Gordon C
    Ann Rheum Dis; 2005 Jan; 64(1):111-3. PubMed ID: 15608308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of bone mineral density and serum bone turnover markers in newly diagnosed systemic lupus erythematosus patients].
    Yao HH; Tang SM; Wang ZM; Zhang X; Chen XY; Gao L; Liu J; Dai YJ; Hu ZH; Zhang XW; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):998-1003. PubMed ID: 30562771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in premenopausal women with systemic lupus erythematosus.
    Uaratanawong S; Deesomchoke U; Lertmaharit S; Uaratanawong S
    J Rheumatol; 2003 Nov; 30(11):2365-8. PubMed ID: 14677178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of long-term glucocorticoids on bone metabolism in systemic lupus erythematosus patients: the prevalence of its anti-inflammatory action upon bone resorption.
    Korczowska I; Olewicz-Gawlik A; Hrycaj P; Lacki J
    Yale J Biol Med; 2003; 76(2):45-54. PubMed ID: 15369631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors of osteoporosis in female SLE patients-extended report.
    Almehed K; Forsblad d'Elia H; Kvist G; Ohlsson C; Carlsten H
    Rheumatology (Oxford); 2007 Jul; 46(7):1185-90. PubMed ID: 17500075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.